Invasion of brain by neurovirulent influenza A virus after intranasal inoculation

Parkinsonism and Related Disorders

Volumn 2, Issue 4, 1996, Pages 187-193

  Yamada, Tatsuo ^a   Yamanaka, Izumi ^a   Takahashi, Mitsuo ^b   Nakajima, Setsuko ^c  

^a CHIBA UNIVERSITY   (Japan)

^b Choju Medical Institute   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Catecholaminergic neuron; Influenza A virus; Intranasal inoculation; Neurovirulence; Substantia nigra

Indexed keywords

EID: 0000531214     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(96)00024-7     Document Type: Article

References (18)

1. Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H. The substantia nigra is a major target for neurovirulent influenza A virus. J. Exp. Med. 1995; 181: 2161-2169.
2. Lindenmann J, Lane CA, Hobson D. The resistance of A2G mice to myxoviruses. J. Immunol. 1963; 90: 942-951.
3. Horisberger MA, McMaster GK, Zeller H, Wathelet MG, Dellis J, Content J. Cloning and sequence analysis of cDNA for Interferon- and virus-induced human Mx proteins reveal that they contain putative guanine nucleotide-binding sites: functional study of the corresponding gene promoter. J. Virol. 1990; 64: 1171-1181.
4. Stranden AM, Staeheli P, Pavlovic J. Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology 1993; 197: 642-651.
5. Sugiura A, Ueda M. Neurovirulence of influenza virus in mice. Virology 1980; 101: 440-449.
6. Nakajima S, Sugiura A. Neurovirulence of influenza virus in mice-II. mechanism of virulence as studied in a neuroblastoma cell line. Virology 1980; 101: 450-457.
7. Ueda M, Sugiura A. Physiological characterization of influenza virus temperature-sensitive mutants defective in the haemagglutinin gene. J. Gen. Virol. 1984; 65: 1889-1897.
8. Yamada T, Akiyama H, McGeer PL. Two types of spheroid bodies in nigral neurons in Parkinson's disease. Can. J. Neurol. Sci. 1991; 18: 287-294.
9. Ado AD, Alekseyeva TM. On the toxic effect of influenza virus on the sympathetic nervous system. Acta Virol. 1957; 1: 161-166.
10. Duffy PE, Wolf A, Hartner DH, Gamboa ET, Hsu KC. Murine influenza virus encephalomyelitis II. Electron-microscopic observation. J. Neuropathol. Exp. Neurol 1973; 32: 72-91.
11. Miyoshi K, Wolf A, Harter DH, Duffy PE, Gamboa ET, Hsu KC. Murine influenza virus encephalomyelitis-I. Neuropathological and immunofluorescence findings. J. Neuropath. Exp. Neurol. 1973; 32: 51-71.
12. Reinacher M, Bonin J, Narayan O, Scholtissek C. Pathogenesis of neurovirulent influenza A virus infection in mice. Lab. Invest. 1983; 49: 686-692.
13. Fiske RA, Klein PA. Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus. Infect. Immunol. 1975; 11: 576-587.
14. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E. Transgenic mice with intracellular immunity to influenza virus. Cell 1990; 62: 51-61.
15. Pavlovic J, Arzet HA, Hefti HP, Frese M, Rost D, Ernst B, Kolb E, Staeheli P, Haller O. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 1995; 69: 4506-4510.
16. Mattock C, Marmot M, Stern G. Could Parkinson's disease follow intra-uterine influenza?: A speculative hypothesis. J. Neurol. Neurosurg. Psychiat. 1988; 51: 753-756.
17. Treves TA, Wechsler M, Rabey JM, Korczyn AD. Risk factors for Parkinson's disease: case-control study with temporal approach. Neurology 1991; 41: 371.
18. Yamada T. Further observations on MxA-positive Lewy bodies in Parkinson's disease brain tissues. Neurosci. Lett. 1995; 195: 41-44.